C2orf40 inhibits hepatocellular carcinoma through interaction with UBR5
Published 2021 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
C2orf40 inhibits hepatocellular carcinoma through interaction with UBR5
Authors
Keywords
-
Journal
JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY
Volume -, Issue -, Pages -
Publisher
Wiley
Online
2021-02-13
DOI
10.1111/jgh.15441
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- ITIH5 and ECRG4 DNA Methylation Biomarker Test (EI-BLA) for Urine-Based Non-Invasive Detection of Bladder Cancer
- (2020) Michael Rose et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Activation of Mitochondrial 2-Oxoglutarate Dehydrogenase by Cocarboxylase in Human Lung Adenocarcinoma Cells A549 Is p53/p21-Dependent and Impairs Cellular Redox State, Mimicking the Cisplatin Action
- (2020) Victoria I. Bunik et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- UBR5 regulates proliferation and radiosensitivity in human laryngeal carcinoma via the p38/MAPK signaling pathway
- (2020) Kai Wang et al. ONCOLOGY REPORTS
- Multifaceted p21 in carcinogenesis, stemness of tumor and tumor therapy
- (2020) Bo-Duan Xiao et al. World Journal of Stem Cells
- PIK3R3 inhibits cell senescence through p53/p21 signaling
- (2020) Qianzhi Chen et al. Cell Death & Disease
- ECRG4 Represses Cell Proliferation and Invasiveness via NFIC/OGN/NF-κB Signaling Pathway in Bladder Cancer
- (2020) Xin Liang et al. Frontiers in Genetics
- Dysregulated Phosphorylation of p53, Autophagy and Stemness Attributes the Mutant p53 Harboring Colon Cancer Cells Impaired Sensitivity to Oxaliplatin
- (2020) Lubna Therachiyil et al. Frontiers in Oncology
- Epigenetic modification and a role for the E3 ligase RNF40 in cancer development and metastasis
- (2020) Junjiang Fu et al. ONCOGENE
- Risk of wild fungi treatment failure: Phallus impudicus-induced telomere damage triggers p21/p53 and p16-dependent cell cycle arrest and may contribute to male fertility reduction in vitro
- (2020) Przemyslaw Solek et al. ECOTOXICOLOGY AND ENVIRONMENTAL SAFETY
- Overexpression of UBR5 promotes tumor growth in gallbladder cancer via PTEN/PI3K/Akt signal pathway
- (2019) Zhen Zhang et al. JOURNAL OF CELLULAR BIOCHEMISTRY
- The E3 ubiquitin ligase UBR 5 interacts with the H/ ACA ribonucleoprotein complex and regulates ribosomal RNA biogenesis in embryonic stem cells
- (2019) Isabel Saez et al. FEBS LETTERS
- A global view of hepatocellular carcinoma: trends, risk, prevention and management
- (2019) Ju Dong Yang et al. Nature Reviews Gastroenterology & Hepatology
- UBE2C is involved in the functions of ECRG4 on esophageal squamous cell carcinoma
- (2018) Linwei Li et al. BIOMEDICINE & PHARMACOTHERAPY
- Downregulation and DNA methylation of ECRG4 in gastric cancer
- (2018) Peng Deng et al. OncoTargets and Therapy
- ECRG4: a new potential target in precision medicine
- (2018) Xin Qin et al. Frontiers of Medicine
- Inactivation of ADAMTS18 by aberrant promoter hypermethylation contribute to lung cancer progression
- (2018) Yan Zhang et al. JOURNAL OF CELLULAR PHYSIOLOGY
- Mutant p53 as a target for cancer treatment
- (2017) Michael J. Duffy et al. EUROPEAN JOURNAL OF CANCER
- Downregulation of esophageal cancer-related gene 4 promotes proliferation and migration of hepatocellular carcinoma
- (2017) Shujian Ge et al. Oncology Letters
- A short synthetic peptide fragment of human C2ORF40 has therapeutic potential in breast cancer
- (2017) Chaoyang Lin et al. Oncotarget
- Downregulated ECRG4 is correlated with lymph node metastasis and predicts poor outcome for nasopharyngeal carcinoma patients
- (2016) J.-Y. Chen et al. Clinical & Translational Oncology
- ECRG4 as a novel tumor suppressor gene inhibits colorectal cancer cell growth in vitro and in vivo
- (2016) Zhengxu Cai et al. TUMOR BIOLOGY
- Downregulated ECRG4 is associated with poor prognosis in renal cell cancer and is regulated by promoter DNA methylation
- (2015) Liya Luo et al. TUMOR BIOLOGY
- Down-regulated ECRG4 expression in breast cancer and its correlation with tumor progression and poor prognosis - A short Report
- (2015) Yanjie You et al. CELLULAR ONCOLOGY
- ECRG4 acts as a tumor suppressor and as a determinant of chemotherapy resistance in human nasopharyngeal carcinoma
- (2015) Yanjie You et al. CELLULAR ONCOLOGY
- EDD induces cell cycle arrest by increasing p53 levels
- (2012) Veronique A.J. Smits CELL CYCLE
- EDD Inhibits ATM-mediated Phosphorylation of p53
- (2011) Shiyun Ling et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- The Tumor Suppressor UCHL1 Forms a Complex with p53/MDM2/ARF to Promote p53 Signaling and Is Frequently Silenced in Nasopharyngeal Carcinoma
- (2010) L. Li et al. CLINICAL CANCER RESEARCH
- The candidate tumor suppressor gene ECRG4 inhibits cancer cells migration and invasion in esophageal carcinoma
- (2010) Linwei Li et al. JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now